These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 987911)

  • 21. Muscarinic postsynaptic events in the cat superior cervical ganglion in situ.
    Haefely W
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 281(2):119-43. PubMed ID: 4273717
    [No Abstract]   [Full Text] [Related]  

  • 22. Central action of narcotic analgesics. I. Catalepsy and stereotypy in rats and narcotic analgesics.
    Malec D; Fidecka S; Langwiński R
    Pol J Pharmacol Pharm; 1977; 29(3):177-93. PubMed ID: 560683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Muscarinic and nicotinic effects on yawning and tongue protruding in the rat.
    Ushijima I; Yamada K; Inoue T; Tokunaga T; Furukawa T; Noda Y
    Pharmacol Biochem Behav; 1984 Aug; 21(2):297-300. PubMed ID: 6541344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of anti-cataleptic effect of scopolamine in mice lacking muscarinic acetylcholine receptor subtype 4.
    Karasawa H; Taketo MM; Matsui M
    Eur J Pharmacol; 2003 May; 468(1):15-9. PubMed ID: 12729838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cholinergic drugs and 4-aminopyridine alter hypoxic-induced behavioral deficits.
    Gibson GE; Pelmas CJ; Peterson C
    Pharmacol Biochem Behav; 1983 Jun; 18(6):909-16. PubMed ID: 6136988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Catalepsy and stereotyped behaviour in rats treated chronically with methadone: relation to brain homovanillic acid content.
    Ashtee L
    J Pharm Pharmacol; 1973 Aug; 25(8):649-51. PubMed ID: 4148435
    [No Abstract]   [Full Text] [Related]  

  • 27. Influence of some cholinomimetic and cholinolytic drugs on halothane shivering in mice.
    Nikki P
    Ann Med Exp Biol Fenn; 1968; 46(4):521-30. PubMed ID: 5731565
    [No Abstract]   [Full Text] [Related]  

  • 28. Neuroleptics: relation between cataleptic and anti-turning actions, and role of the cholinergic system.
    Muller P; Seeman P
    J Pharm Pharmacol; 1974 Dec; 26(12):981-4. PubMed ID: 4156868
    [No Abstract]   [Full Text] [Related]  

  • 29. Enhancement of haloperidol-induced catalepsy by nicotine: an investigation of possible mechanisms.
    Boye SM; Clarke PB
    Can J Physiol Pharmacol; 2000 Nov; 78(11):882-91. PubMed ID: 11100936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic nicotine treatment potentiates behavioral responses to dopaminergic drugs in rats.
    Suemaru K; Gomita Y; Furuno K; Araki Y
    Pharmacol Biochem Behav; 1993 Sep; 46(1):135-9. PubMed ID: 7902980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of the effects of muscarinic and nicotinic anticholinergic drugs on habituation and fear conditioning in rats.
    Avis HH; Pert A
    Psychopharmacologia; 1974 Jan; 34(3):209-22. PubMed ID: 4819975
    [No Abstract]   [Full Text] [Related]  

  • 32. Scopolamine self-administration: cholinergic involvement in reward mechanisms.
    Glick SD; Guido RA
    Life Sci; 1982 Aug; 31(9):909-13. PubMed ID: 7176819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of cholinergic drugs on prey-killing by rodents.
    Wnek DJ; Leaf RC
    Physiol Behav; 1973 Jun; 10(6):1107-13. PubMed ID: 4736903
    [No Abstract]   [Full Text] [Related]  

  • 34. Preferential release of adrenaline from the adrenal medulla by muscarine and pilocarpine.
    Douglas WW; Poisner AM
    Nature; 1965 Dec; 208(5015):1102-3. PubMed ID: 5870567
    [No Abstract]   [Full Text] [Related]  

  • 35. Responses of thalamic neurones to iontophoretically applied drugs.
    McCance I; Phillis JW; Westerman RA
    Nature; 1966 Feb; 209(5024):715-6. PubMed ID: 5922134
    [No Abstract]   [Full Text] [Related]  

  • 36. Rapid induction of supersensitivity to muscarinic antagonists-induced motor excitation by continuous stimulation of cholinergic receptors.
    Fernando JC; Hoskins B; Ho IK
    Life Sci; 1985 Sep; 37(9):883-92. PubMed ID: 4041002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition by cholinergic agonists of the prolactin release induced by morphine.
    Muraki T; Tokunaga Y; Nakadate T; Kato R
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Sep; 308(3):249-54. PubMed ID: 503252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholinergic mechanisms and cataplexy in dogs.
    Delashaw JB; Foutz AS; Guilleminault C; Dement WC
    Exp Neurol; 1979 Dec; 66(3):745-57. PubMed ID: 573697
    [No Abstract]   [Full Text] [Related]  

  • 39. Nicotinic and muscarinic activity of benzyltrimethyl-ammonium and its alpha-, beta- and gamma-substituted pyridylmethyltrimethylammonium analogs.
    Hamilton JT; Rubinstein HM
    J Pharmacol Exp Ther; 1968 Mar; 160(1):112-23. PubMed ID: 5639098
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of agonists and antagonists of cholinergic receptors on self-stimulation of the medial prefrontal cortex of the rat.
    Vives F; Mora F
    Gen Pharmacol; 1986; 17(1):63-7. PubMed ID: 3949150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.